Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Real-world outcomes of teclistamab in triple-exposed relapsed/refractory multiple myeloma: Brazilian single-center experience

Mariana Kerbauy, Danielle Ovigli, Newton Centuriao, Lucila Kerbauy, Ricardo Helman, Guilherme Perini, Fabio Santos, Andreza Ribeiro, Leonardo Arcuri, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7607.

https://doi.org/10.1182/blood-2025-7607

Published: 2025

Journal Articles

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Blood (2025) 146 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2025-7066

Published: 2025

Journal Articles

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study

Leonardo Arcuri, Mariana Kerbauy, Lucila Kerbauy, Juliana Rocha, Carolina Marques, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Ana de Rezende, Eduardo Weltman, Roberto Sakuraba, Andreza Ribeiro, Marcos de Lima, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7738.

https://doi.org/10.1182/blood-2025-7738

Published: 2025

Journal Articles

Balancing efficacy and safety: IL-15 BCMA CAR-T cells vs. 2nd generation CAR-T in preclinical myeloma model

Jamile Ramos, Cleyson Barros, Thiago Mitsugi, Lays Trajano, Erica Vidal, Ingrid Souza, Robledo Ferreira, Yasmin Mamirato, Barbara Dos Reis, Julia Azevedo, Raquel M A Paiva, Oswaldo Okamoto, Larissa Cardoso, Nelson Hamerschlak, Lucila Kerbauy

Blood (2025) 146 (Supplement 1): 7635.

https://doi.org/10.1182/blood-2025-7635

Published: 2025

Journal Articles

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Blood (2025) 146 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2025-3673

Published: 2025

Journal Articles

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Blood (2025) 146 (Supplement 1): 5391.

https://doi.org/10.1182/blood-2025-5391

Published: 2025

Journal Articles

Manufacturing variability of CAR-T cells in patients with B-cell lymphoma: Findings from the carthiae-1 clinical trial

Raquel Paiva, Julia Teixeira Cottas de Azevedo, João Agostinho Machado-Neto, Denise Oliveira, Juliana Godoy, Keli Lima, Heitor Andrade, Mariana Velloso, Fernanda Assir, Isabel Bello, Oswaldo Okamoto, Mariana Kerbauy, Jose Kutner, Nelson Hamerschlak, Lucila Kerbauy

Blood (2025) 146 (Supplement 1): 7701.

https://doi.org/10.1182/blood-2025-7701

Published: 2025

Journal Articles

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Blood (2025) 146 (Supplement 1): 1854.

https://doi.org/10.1182/blood-2025-1854

Published: 2025

Journal Articles

High vs. low intensity chemotherapy in AML: Survival and transplant outcomes in a brazilian experience

Newton Centurião, Danielle Ovigli, Fernando Moura, Andreza Ribeiro, Cinthya Da Silva, Guilherme Perini, Ricardo Helman, Lucila Kerbauy, Juliana Rocha, João Guerra, Jose Kutner, Fabio Pires, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 6900.

https://doi.org/10.1182/blood-2025-6900

Published: 2025

Journal Articles

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 1361.

https://doi.org/10.1182/blood-2025-1361

Published: 2025

Journal Articles

Results of the first Latin American point of care manufactured, Phase I anti- CD19 CAR-T study (CARTHIAE) for Relapsed/Refractory B-cell neoplasms

Blood (2025) 146 (Supplement 1): 2405.

https://doi.org/10.1182/blood-2025-2405

Published: 2025

Journal Articles

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for hematopoietic cell transplantation in patients aged 60 years or older: A prospective study

Leonardo Arcuri, Mariana Kerbauy, Lucila Kerbauy, Juliana Rocha, Carolina Marques, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Ana de Rezende, Eduardo Weltman, Andreza Ribeiro, Marcos de Lima, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 2439.

https://doi.org/10.1182/blood-2025-2439

Published: 2025

Journal Articles

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Blood (2022) 140 (Supplement 1): 415–416.

https://doi.org/10.1182/blood-2022-156125

Published: 2022

Journal Articles

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Leonardo Javier Arcuri, Fabio Pires de Souza Santos, Lucila Kerbauy, Mariana Nassif Kerbauy, Andreza Feitosa Ribeiro, Nelson Hamerschlak

Blood (2022) 140 (Supplement 1): 4767–4769.

https://doi.org/10.1182/blood-2022-156282

Published: 2022

Journal Articles

Clinical Validation of Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of B Neoplasia

Lucila Kerbauy, Larissa Leggieri Coa, Micheli Severo Sielski, Juliana Aparecida Preto Godoy, Andrea Tiemi Kondo, Julia Teixeira Cottas Azevedo, Augusto Barbosa, Jr., Oswaldo Keith Okamoto, Jose Mauro Kutner, Nelson Hamerschlak, Raquel de Melo Alves Paiva

Blood (2022) 140 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2022-170045

Published: 2022

Journal Articles

Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells

Heitor Duarte Andrade, Andrea Tiemi Kondo, Lucila Kerbauy, Raquel de Melo Alves Paiva, Denise Cristine Oliveira, Larissa Leggieri Coa, Kelen Cristina Arcuri Alvarez, Mariana Lorenzi Savioli, Bruna Melo Coelho Loureiro, Oswaldo Keith Okamoto, Nelson Hamerschlak, Jose Mauro Kutner, Juliana Aparecida Preto Godoy

Blood (2021) 138 (Supplement 1): 4302.

https://doi.org/10.1182/blood-2021-154291

Published: 2021

Journal Articles

Risk Factors for Adverse Outcomes Following Haploidentical Hematopoietic Cell Transplantation with Posttransplant Cyclophosphamide: A Two-Center Analysis

Viviane De Jesus Torres Lima, Anderson Felipe Felipe Da Silva, Andreza Alice Feitosa Ribeiro, Mariana Nassif Kerbauy, Lucila Kerbauy, Cinthya Correa Silva, Leonardo Javier Arcuri, Nelson Hamerschlak

Blood (2021) 138 (Supplement 1): 4889.

https://doi.org/10.1182/blood-2021-153961

Published: 2021

Journal Articles

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

Blood (2019) 134 (Supplement_1): 1944.

https://doi.org/10.1182/blood-2019-125276

Published: 2019

Journal Articles

Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies

Blood (2019) 134 (Supplement_1): 1936.

https://doi.org/10.1182/blood-2019-126739

Published: 2019

Journal Articles

Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells

Enli Liu, MD, Sonny Ang, PhD, Yijiu Tong, Li Li, MD, Rafet Basar, MD, Lucila Kerbauy, MD, May Daher, Pinaki P Banerjee, PhD, Francesca Lorraine Wei Inng Lim, MD, Indreshpal Kaur, PhD, Richard E Champlin, MD, Elizabeth J. Shpall, MD, Katy Rezvani, MD PhD

Blood (2018) 132 (Supplement 1): 2061.

https://doi.org/10.1182/blood-2018-99-118804

Published: 2018

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-world outcomes of teclistamab in triple-exposed relapsed/refractory multiple myeloma: Brazilian single-center experience

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study

Balancing efficacy and safety: IL-15 BCMA CAR-T cells vs. 2nd generation CAR-T in preclinical myeloma model

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Manufacturing variability of CAR-T cells in patients with B-cell lymphoma: Findings from the carthiae-1 clinical trial

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

High vs. low intensity chemotherapy in AML: Survival and transplant outcomes in a brazilian experience

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Results of the first Latin American point of care manufactured, Phase I anti- CD19 CAR-T study (CARTHIAE) for Relapsed/Refractory B-cell neoplasms

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for hematopoietic cell transplantation in patients aged 60 years or older: A prospective study

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Clinical Validation of Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of B Neoplasia

Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells

Risk Factors for Adverse Outcomes Following Haploidentical Hematopoietic Cell Transplantation with Posttransplant Cyclophosphamide: A Two-Center Analysis

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies

Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only